As per the recently published report by MarketsandMarkets?, The report "DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029", is projected to reach USD 21.2 billion by 2029 from USD 13.3 billion in 2024, at a CAGR of 9.7 % during the forecast period.
- 350? ?Market Data Tables
- 48? ? ?Figures
- 333? ?Pages and in-depth TOC on?" DNA Diagnostics Market - Global Forecast to 2029”
Some of the prominent key players are:
- Illumina, Inc. (US),
- Danaher Corporation (US),
- F. Hoffmann-La Roche Ltd. (Switzerland),
- bioMérieux (France), Hologic, Inc. (US),
- QIAGEN (Germany),
- Thermo Fisher Scientific Inc. (US),
- Agilent Technologies, Inc. (US), and many more......
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the DNA Diagnostics Market.
- Based on offering, the global DNA diagnostics market is segmented into reagents & kits, instruments, and services & software. In 2023, the reagents & kits segment accounted for the largest share of the DNA diagnostics market. With the growing prevalence of diseases and the need for accurate and timely diagnoses, the volume of DNA diagnostic tests is consistently increasing.
- Based on specimens, the DNA diagnostics market is segmented into blood, serum, and plasma, urine, and other specimens. In 2023, the blood, serum, and plasma segment accounted for the largest share of the DNA diagnostics market.
- Based on applications, the DNA diagnostics market is segmented into infectious disease diagnostics, oncology testing, prenatal, pre-implantation, myogenic disorders, and other applications. In 2023, the infectious disease diagnostic segment accounted for the largest share of the DNA diagnostics market. Hepatitis, HIV, CT/NG, HIV, and HPV are the common infectious diseases for which DNA diagnostic tests are performed.
- Based on end users, the DNA diagnostics market is segmented into hospitals and clinics, diagnostic laboratories, and other end users. In 2023, the diagnostics laboratories segment accounted for the largest share of the DNA diagnostics market. Diagnostics laboratories offer a wide range of DNA diagnostic tests for various diseases and conditions.
- The global DNA diagnostics market is divided into six key regions: North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries. The Asia Pacific is projected to register the highest CAGR of 11.1% in the DNA diagnostics market during the forecast period.
Growth in this market is primarily driven by the ability of DNA diagnostics to identify the genetic predispositions and susceptibility to chronic diseases, allowing for personalized and preventive healthcare strategies. Additionally, government initiatives, schemes, or funding activities that support and promote innovation and development provide growth opportunities in the DNA diagnostics market.
